Thursday, March 30, 2023
Time: 11:00 AM-12:00 PM EST
Experts from CROs, patient advocacy, and the pharmaceutical industry will share insights on the role of decentralised clinical trials (DCTS) as a potential option to make clinical research more accessible to participants who may not otherwise be able to participate. The panel will discuss important topics, such as:
- Stakeholder engagement and resources needed to determine if a DCT is an optimal option to improve trial accessibility
- What capabilities are needed to successful execute a DCT through the lens of accessibility
Moderator:
.png?crop=yes&w=240&h=240&itok=q9i6WN8O){kind=icon}
Afshawn Chakamian
Director of Therapeutic Expertise, ICON plc
Panelists:
.png?crop=yes&w=240&h=240&itok=jG3f1VXD){kind=icon}
Ashmee Bharadia
Vice President, In Home Services, Accellacare
Sneha Dave
Executive Director, Generation Patient
Craig Lipset
Co-Chair, Decentralized Trials & Research Alliance, Adjunct Assistant Professor, Rutgers University, Vice President, Foundation for Sarcoidosis Research, Managing Partner, Clinical Innovation Partners
Katie Wright
Person living with VEDS; Host of Staying Connected podcast